Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page
- Check7 days agoChange DetectedThe study record for the completed UCART19 Phase 1 trial is available, with details on its participants, treatment, study sites, and measured outcomes. It also includes publications and information on requesting access to individual participant data.SummaryDifference48%

- Check14 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2. The study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice announces a transition in NIH content from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check27 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error screen, indicating access is blocked to the study record, with the site header and footer visible as part of the error layout.SummaryDifference17%

Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.